My ePortfolio Register   

SIOG 2016 /
Paclitaxel in elderly women with ovarian, primary peritoneal or fallopian tube cancer

17th - 19th Nov 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 22.11.16
Views: 284
Rating:

Dr William Tew - Memorial Sloan Cancer Center, New York, USA

Dr Tew speaks with ecancertv at SIOG 2016 about the gynaecologic oncology group (GOG) study into geriatric assessment and outcomes with carboplatin and weekly low-dose Paclitaxel in elderly women with ovarian, primary peritoneal or fallopian tube cancer.

This service has been kindly supported by an unrestricted grant from Merck/MSD. 

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence